Mechanistic Underlying Anti-diabetic Potential of Eclipta alba Flavonoids against Aldose Reductase Inhibitory Action

Background: One of the main factors contributing to morbidity and mortality in the world's population is diabetes mellitus. The primary symptoms of this condition are hyperglycemia, or high blood sugar, which is followed by polydipsia and polyuria. Damage to the retina, loss of kidney function, and nerve damage are examples of subsequent consequences. Moreover, diabetes mellitus will accelerate the development of cardiovascular disease. Eclipta alba (L.) Hassk. (Also known as Eclipta prostrata Roxb.) belongs to the Asteraceae family and is commonly known as false daisy in English and bhringoraj or bhringraj in Bangladesh and India. It is regarded as a weed of ethnomedicinal significance. Pharmacological activities of plant extracts and individual phytoconstituents have revealed anticancer, hepatoprotective, snake venom neutralizing, anti-inflammatory, and antimicrobial properties. Purpose: This study aimed to assess the antidiabetic activity of Eclipta alba leaf flavonoid through in-silico molecular docking. Method: Aldose reductase was chosen as the target proteins in the current investigation. The bond was found using the Auto Dock software using a grid-based docking method. Compounds' 2D structures were generated, converted to 3D, and subsequently energetically lowered up to an arms gradient of 0.01 using the Merck Molecular Force Field (MMFF). Result: Flavonoids of E.alba found to be effective anti-diabetic component and effectively binds to be target protein Aldose reductase with binding energy -8.96, -6.02 & -5.86 kcalmol-1 for apigenin, syringic acid & vanillic acid respectively. Conclusion: The finding of the in-silico molecular docking showed that both lead compound is effective binds & inhibitory action on target protein. The molecular docking of ligands like apigenin, syringic acid & vanillic acid with Aldose reductase receptor revealed that it has exhibited the chemical interaction with the amino acids in the active pockets.

Authors

Publication Details

Journal
South Asian Research Journal of Pharmaceutical Sciences
Published
2025-02-26
DOI
https://doi.org/10.36346/sarjps.2025.v07i01.006
Citations
1
Primary Topic
Medicinal Plants and Neuroprotection
Type
article
Field-Weighted Citation Impact
2.38
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mechanistic Underlying Anti-diabetic Potential of Eclipta alba Flavonoids against Aldose Reductase Inhibitory Action

Jitender K Malik, K. R. Maurya
1 citations
South Asian Research Journal of Pharmaceutical Sciences
Medicinal Plants and Neuroprotection
2.38
article

Mechanistic Underlying Anti-diabetic Potential of Eclipta alba Flavonoids against Aldose Reductase Inhibitory Action

Jitender K Malik, K. R. Maurya
article en
1 citations

Abstract

Background: One of the main factors contributing to morbidity and mortality in the world's population is diabetes mellitus. The primary symptoms of this condition are hyperglycemia, or high blood sugar, which is followed by polydipsia and polyuria. Damage to the retina, loss of kidney function, and nerve damage are examples of subsequent consequences. Moreover, diabetes mellitus will accelerate the development of cardiovascular disease. Eclipta alba (L.) Hassk. (Also known as Eclipta prostrata Roxb.) belongs to the Asteraceae family and is commonly known as false daisy in English and bhringoraj or bhringraj in Bangladesh and India. It is regarded as a weed of ethnomedicinal significance. Pharmacological activities of plant extracts and individual phytoconstituents have revealed anticancer, hepatoprotective, snake venom neutralizing, anti-inflammatory, and antimicrobial properties. Purpose: This study aimed to assess the antidiabetic activity of Eclipta alba leaf flavonoid through in-silico molecular docking. Method: Aldose reductase was chosen as the target proteins in the current investigation. The bond was found using the Auto Dock software using a grid-based docking method. Compounds' 2D structures were generated, converted to 3D, and subsequently energetically lowered up to an arms gradient of 0.01 using the Merck Molecular Force Field (MMFF). Result: Flavonoids of E.alba found to be effective anti-diabetic component and effectively binds to be target protein Aldose reductase with binding energy -8.96, -6.02 & -5.86 kcalmol-1 for apigenin, syringic acid & vanillic acid respectively. Conclusion: The finding of the in-silico molecular docking showed that both lead compound is effective binds & inhibitory action on target protein. The molecular docking of ligands like apigenin, syringic acid & vanillic acid with Aldose reductase receptor revealed that it has exhibited the chemical interaction with the amino acids in the active pockets.

South Asian Research Journal of Pharmaceutical SciencesVol. 7(01)
Openalex Percentile: Top 15%
Medicinal Plants and Neuroprotection
2.38
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Mechanistic Underlying Anti-diabetic Potential of Eclipta alba Flavonoids against Aldose Reductase Inhibitory Action — Jitender K Malik, K. R. Maurya · South Asian Research Journal of Pharmaceutical Sciences (2025) | TGRS Research Map | TGRS